The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives

Syed Hassan Abbas Kazmi, Sudarshana Datta, Gerald Chi, Tarek Nafee, Megan Yee, Akshun Kalia, Sadaf Sharfaei, Fahimehalsadat Shojaei, Sabawoon Mirwais, C Michael Gibson Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, M...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kazmi SHA, Datta S, Chi G, Nafee T, Yee M, Kalia A, Sharfaei S, Shojaei F, Mirwais S, Gibson CM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/27961046d9c740df8c3101a10ad370b4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:27961046d9c740df8c3101a10ad370b4
record_format dspace
spelling oai:doaj.org-article:27961046d9c740df8c3101a10ad370b42021-12-02T09:10:06ZThe AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives1179-1470https://doaj.org/article/27961046d9c740df8c3101a10ad370b42020-01-01T00:00:00Zhttps://www.dovepress.com/the-angelmed-guardianreg-system-in-the-detection-of-coronary-arter-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Syed Hassan Abbas Kazmi, Sudarshana Datta, Gerald Chi, Tarek Nafee, Megan Yee, Akshun Kalia, Sadaf Sharfaei, Fahimehalsadat Shojaei, Sabawoon Mirwais, C Michael Gibson Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USACorrespondence: C Michael GibsonPERFUSE Study Group, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 930 Commonwealth Ave. #3, Boston, MA 02215, USATel +1-617-975-9950Email mgibson@bidmc.harvard.eduAbstract: Total ischemic time, which specifies the time from the onset of chest pain to initiation of reperfusion during percutaneous coronary intervention, consists of two intervals: symptom to door time and door to balloon time. A door to balloon time of 90 mins or less has become a quality-of-care metric in the management of ST elevation myocardial infarction (STEMI). While national efforts made by the American College of Cardiology (ACC) and American Heart Association (AHA) have curtailed in-hospital door to balloon time over the years, a reduction in pre-hospital symptoms to door time presents a challenge in modern interventional Cardiology. Early and complete revascularization has been associated with improved clinical outcomes in MI and strategies that may help reduce symptom to door time, and thus the total ischemic time, are crucial. Rapidly evolving ST-segment changes commonly develop prior to ischemia-related symptom onset, and are detectable even in patients with clinically unrecognized silent MIs. Therefore, a highly intelligent ischemia detection system that alerts patients of ST segment deviation may allow for rapid identification of acute coronary occlusion. The AngelMed Guardian® System is a cardiac activity monitoring and alerting system designed for rapid identification of intracardiac ST-segment changes among patients at a high risk for recurrent ACS events. This article reviews the clinical studies evaluating the design, safety and efficacy of the AngelMed Guardian System and discusses the clinical implications of the device.Keywords: acute coronary syndrome, myocardial infarction, ST elevation myocardial infarction, ischemia monitoring, electrocardiographyKazmi SHADatta SChi GNafee TYee MKalia ASharfaei SShojaei FMirwais SGibson CMDove Medical Pressarticleacute coronary syndromemyocardial infarctionst elevation myocardial infarctionischemia monitoringelectrocardiographyMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 13, Pp 1-12 (2020)
institution DOAJ
collection DOAJ
language EN
topic acute coronary syndrome
myocardial infarction
st elevation myocardial infarction
ischemia monitoring
electrocardiography
Medical technology
R855-855.5
spellingShingle acute coronary syndrome
myocardial infarction
st elevation myocardial infarction
ischemia monitoring
electrocardiography
Medical technology
R855-855.5
Kazmi SHA
Datta S
Chi G
Nafee T
Yee M
Kalia A
Sharfaei S
Shojaei F
Mirwais S
Gibson CM
The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives
description Syed Hassan Abbas Kazmi, Sudarshana Datta, Gerald Chi, Tarek Nafee, Megan Yee, Akshun Kalia, Sadaf Sharfaei, Fahimehalsadat Shojaei, Sabawoon Mirwais, C Michael Gibson Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USACorrespondence: C Michael GibsonPERFUSE Study Group, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 930 Commonwealth Ave. #3, Boston, MA 02215, USATel +1-617-975-9950Email mgibson@bidmc.harvard.eduAbstract: Total ischemic time, which specifies the time from the onset of chest pain to initiation of reperfusion during percutaneous coronary intervention, consists of two intervals: symptom to door time and door to balloon time. A door to balloon time of 90 mins or less has become a quality-of-care metric in the management of ST elevation myocardial infarction (STEMI). While national efforts made by the American College of Cardiology (ACC) and American Heart Association (AHA) have curtailed in-hospital door to balloon time over the years, a reduction in pre-hospital symptoms to door time presents a challenge in modern interventional Cardiology. Early and complete revascularization has been associated with improved clinical outcomes in MI and strategies that may help reduce symptom to door time, and thus the total ischemic time, are crucial. Rapidly evolving ST-segment changes commonly develop prior to ischemia-related symptom onset, and are detectable even in patients with clinically unrecognized silent MIs. Therefore, a highly intelligent ischemia detection system that alerts patients of ST segment deviation may allow for rapid identification of acute coronary occlusion. The AngelMed Guardian® System is a cardiac activity monitoring and alerting system designed for rapid identification of intracardiac ST-segment changes among patients at a high risk for recurrent ACS events. This article reviews the clinical studies evaluating the design, safety and efficacy of the AngelMed Guardian System and discusses the clinical implications of the device.Keywords: acute coronary syndrome, myocardial infarction, ST elevation myocardial infarction, ischemia monitoring, electrocardiography
format article
author Kazmi SHA
Datta S
Chi G
Nafee T
Yee M
Kalia A
Sharfaei S
Shojaei F
Mirwais S
Gibson CM
author_facet Kazmi SHA
Datta S
Chi G
Nafee T
Yee M
Kalia A
Sharfaei S
Shojaei F
Mirwais S
Gibson CM
author_sort Kazmi SHA
title The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives
title_short The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives
title_full The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives
title_fullStr The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives
title_full_unstemmed The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives
title_sort angelmed guardian® system in the detection of coronary artery occlusion: current perspectives
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/27961046d9c740df8c3101a10ad370b4
work_keys_str_mv AT kazmisha theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT dattas theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT chig theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT nafeet theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT yeem theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT kaliaa theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT sharfaeis theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT shojaeif theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT mirwaiss theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT gibsoncm theangelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT kazmisha angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT dattas angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT chig angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT nafeet angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT yeem angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT kaliaa angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT sharfaeis angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT shojaeif angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT mirwaiss angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
AT gibsoncm angelmedguardianregsysteminthedetectionofcoronaryarteryocclusioncurrentperspectives
_version_ 1718398173581410304